European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 2 , Pages 120-123 , December 2009

Contribution of myo-inositol to reproduction

  • E. Papaleo

      Affiliations

    • Centro Natalità, Gynaecological-Obstetric Department, San Raffaele Hospital, Vita-Salute San Raffaele, Milano, Italy
    • Corresponding Author InformationCorresponding author at: Centro Natalità, Gynaecological-Obstetric Department, IRCCS San Raffaele, via Olgettina 60, 20132 Milano, Italy. Tel.: +39 02 26432202; fax: +39 02 26434311.
  • ,
  • V. Unfer

      Affiliations

    • AGUNCO Obstetrics and Gynecology Centre, via G. Cassiani, Rome 15-00155, Italy
  • ,
  • J.P. Baillargeon

      Affiliations

    • Department of Medicine, Université de Sherbrooke, Sherbrooke, Canada
  • ,
  • T.T. Chiu

      Affiliations

    • Department of Obstetrics & Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China

Received 9 April 2009 ,Revised 11 August 2009 ,Accepted 11 September 2009.

References 

  1. Beemster P, Groenen P, Steegers-Theunissen R. Involvement of inositol in reproduction. Nutr Rev. 2002;60(3):80–87
  2. Kane MT. The effects of water soluble vitamins on the expansion of rabbit blastocysts. J Exp Zool. 1988;245:220–223
  3. Dove SK, Michell RH. Inositol lipids and phosphates in cell control. Neurotransmissions. 2000;16:3–17
  4. Berridge MJ. Inositol lipids and cell proliferation. Biochim Biophys Acta. 1987;907:33–45
  5. Downes CP. The cellular function of myo-inositol. Biochem Soc Trans. 1989;17:259–268
  6. Fahy MM, Kane MT. Incorporation of [3H] inositol into phosphoinositides and inositol phosphates by rabbit blastocysts. Mol Reprod Dev. 1993;34:391–395
  7. Holm P, Booth PJ, Schmidt MH, Greve T, Callesen H. High bovine blastocyst development in a static in vitro production system using SOFaa medium supplemented with sodium citrate and myo-inositol with or without serum-proteins. Theriogenology. 1999;52:683–700
  8. Berridge MJ, Irvine RF. Inositol phosphate and cell signalling. Nature. 1989;306:197–205
  9. Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Ann Rev Nutr. 1986;6:563–597
  10. Kane MT, Norris M, Harrison RAP. Uptake and incorporation of inositol by preimplantation mouse embryos. J Reprod Fert. 1992;95:617–625
  11. Berridge MJ . Inositol trisphosphate and calcium signalling. Nature. 1993;361:315–325
  12. Downes CP, Currie RA. Lipid signalling. Curr Biol. 1998;8:R865–R867
  13. Balla T. Inositol-lipid binding motifs: signal integrators through protein-lipid and protein–protein interactions. J Cell Sci. 2005;118:2093–2104
  14. Divecha N, Irvine RF. Phospholipid signalling. Cell. 1995;80:269–278
  15. Herbert M, Gillespie JI, Murdoch AP. Development of calcium signaling mechanisms during maturation of human oocytes. Mol Hum Reprod. 1997;3:965–973
  16. Berridge MJ, Downes CP, Hanley MR. Neural developmental actions of lithium: a unifying hypothesis. Cell. 1989;59:411–419
  17. Berridge MJ. Regulation of calcium spiking in mammalian oocytes through a combination of inositol trisphosphate-dependent entry and release. Mol Hum Reprod. 1996;2:383–390
  18. Carroll J, Jones KT, Whittingham DG. Ca2+ release and the development of Ca2+ release mechanisms during oocyte maturation: a prelude to fertilization. Rev Reprod. 1996;1:137–143
  19. Tesarik J, Sousa M. Mechanism of calcium oscillations in human oocytes: a two-store model. Mol Hum Reprod. 1996;2:383–385
  20. Mehlmann LM, Mikoshiba K, Kline D. Redistribution and increase in cortical inositol 1,4,5-trisphosphate receptors after meiotic maturation of the mouse oocyte. Dev Biol. 1996;180:489–498
  21. Goud PT, Goud AP, Van Oostveldt P, Dhont M. Presence and dynamic redistribution of type 1 inositol 1,4,5-trisphosphate receptors in human oocytes and embryos during in vitro maturation, fertilization and early cleavage divisions. Mol Hum Reprod. 1999;5:441–451
  22. Goud PT, Goud AP, Leybaert L, et al. Inositol 1,4,5-trisphosphate receptor function in human oocytes: calcium responses and oocyte activation-related phenomena induced by photolytic release of InsP3 are blocked by a specific antibody to the type I receptor. Mol Hum Reprod. 2002;8:912–918
  23. Pesty A, Lefevre B, Kubiak J, Geraud G, Tesarik J, Maro B. Mouse oocyte maturation is affected by lithium via the polyphosphoinositide metabolism and the microtubule network. Mol Reprod Dev. 1994;38:187–199
  24. Delisle S, Blondel O, Longo FJ, Schnabel WE, Bell GI, Welsh MJ. Expression of inositol 1,4,5-trisphosphate receptors changes the Ca2+ signal of Xenopus oocytes. Am J Physiol-cell Physiol. 1996;270:c1255–c1261
  25. Chiu TTY, Rogers MS, Briton-Jones C, Haines C. Effects of myo-inositol on the in vitro maturation and subsequent development of mouse oocytes. Hum Reprod. 2003;18:408–416
  26. Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002;17(6):1591–1596
  27. Paolo GD, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443:651–657
  28. Larner J. Mediators of postreceptor action of insulin. Am J Med. 1983;74:38–51
  29. Larner J. Insulin-signaling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology. Diabetes. 1988;37:262–275
  30. Saltiel AR. Second messengers of insulin action. Diabetes Care. 1990;13:244–256
  31. Nestler E, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340:1314–1320
  32. Gerli S, Mignosa M, Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2003;7:151–159
  33. Gerli S, Papaleo E, Ferrari A, et al. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci. 2007;11:347–354
  34. Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol. 2007;23:700–703
  35. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008;24(3):139–144
  36. Baillargeon JP, Diamanti-Kandarakis E, Ostlund RE, Apridonidze T, Iuorno MJ, Nestler JE. Altered d-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care. 2006;29(2):300–305
  37. Baillargeon JP, Nestler JE, Ostlund RE, Apridonidze T, Diamanti-Kandarakis E. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Hum Reprod. 2008;23(June (6)):1439–1446[Epub 2008 Mar 29]
  38. Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril. 2009;91(5):1750–1754
  39. Minozzi M, D’Andrea G, Unfer V. Treatment of hirsutism with myo-inositol: a prospective clinical study. Reprod Biomed Online. 2008;17(4):579–582
  40. Jousan FD, Oliveira LJ, Hansen PJ. Short-term culture of in vitro produced bovine preimplantation embryos with insulin-like growth factor-i prevents heat shock-induced apoptosis through activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol Reprod Dev. 2008;75(4):681–688
  41. Lowther KM, Weitzman VN, Maier D, Mehlmann LM. Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes. Biol Reprod. 2009;81(July (1)):147–154[Epub 2009 Mar 18]
  42. Consensus on infertility diagnosis Rotterdam.
  43. Consensus on infertility treatment related to polycystic ovary syndrome. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group* March 2–3, 2007, Thessaloniki, Greece. Hum Reprod 2007;23:462–477.
  44. Palomba S, Orio F, Zullo F. Ovulation induction in women with polycystic ovary syndrome. Fertil Steril. 2008;86(Suppl 1):s26–s27
  45. Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome; 2006.

PII: S0301-2115(09)00546-6

doi: 10.1016/j.ejogrb.2009.09.008

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 2 , Pages 120-123 , December 2009